Cencora, Inc. (COR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - Cencora is a global pharmaceutical services healthcare company that ships over 1 billion medications annually through its MSO investments [2] - The company reported a 9% year-over-year revenue increase and a 16% increase in both adjusted operating income and adjusted diluted EPS, while generating $3 billion in free cash flow [2] Strategic Focus - Cencora emphasizes its purpose-driven approach, aiming to create healthier futures, which is a key indicator of its operational outcomes [3] - The company is strategically focused on four drivers, including digital transformation, optimizing business processes, and leveraging advanced analytics and AI to enhance business operations [3]